425 related articles for article (PubMed ID: 20547815)
1. Adaptive resistance to the "last hope" antibiotics polymyxin B and colistin in Pseudomonas aeruginosa is mediated by the novel two-component regulatory system ParR-ParS.
Fernández L; Gooderham WJ; Bains M; McPhee JB; Wiegand I; Hancock RE
Antimicrob Agents Chemother; 2010 Aug; 54(8):3372-82. PubMed ID: 20547815
[TBL] [Abstract][Full Text] [Related]
2. Cationic antimicrobial peptides activate a two-component regulatory system, PmrA-PmrB, that regulates resistance to polymyxin B and cationic antimicrobial peptides in Pseudomonas aeruginosa.
McPhee JB; Lewenza S; Hancock RE
Mol Microbiol; 2003 Oct; 50(1):205-17. PubMed ID: 14507375
[TBL] [Abstract][Full Text] [Related]
3.
Janet-Maitre M; Job V; Bour M; Robert-Genthon M; Brugière S; Triponney P; Cobessi D; Couté Y; Jeannot K; Attrée I
mBio; 2024 Mar; 15(3):e0221123. PubMed ID: 38345374
[TBL] [Abstract][Full Text] [Related]
4. Development of colistin resistance in pmrA-, phoP-, parR- and cprR-inactivated mutants of Pseudomonas aeruginosa.
Lee JY; Chung ES; Na IY; Kim H; Shin D; Ko KS
J Antimicrob Chemother; 2014 Nov; 69(11):2966-71. PubMed ID: 24994873
[TBL] [Abstract][Full Text] [Related]
5. Adaptive and Mutational Responses to Peptide Dendrimer Antimicrobials in Pseudomonas aeruginosa.
Ben Jeddou F; Falconnet L; Luscher A; Siriwardena T; Reymond JL; van Delden C; Köhler T
Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 32015046
[TBL] [Abstract][Full Text] [Related]
6. PhoQ mutations promote lipid A modification and polymyxin resistance of Pseudomonas aeruginosa found in colistin-treated cystic fibrosis patients.
Miller AK; Brannon MK; Stevens L; Johansen HK; Selgrade SE; Miller SI; Høiby N; Moskowitz SM
Antimicrob Agents Chemother; 2011 Dec; 55(12):5761-9. PubMed ID: 21968359
[TBL] [Abstract][Full Text] [Related]
7. Role of Pseudomonas aeruginosa PhoP-phoQ in resistance to antimicrobial cationic peptides and aminoglycosides.
Macfarlane ELA; Kwasnicka A; Hancock REW
Microbiology (Reading); 2000 Oct; 146 ( Pt 10)():2543-2554. PubMed ID: 11021929
[TBL] [Abstract][Full Text] [Related]
8. PmrB mutations promote polymyxin resistance of Pseudomonas aeruginosa isolated from colistin-treated cystic fibrosis patients.
Moskowitz SM; Brannon MK; Dasgupta N; Pier M; Sgambati N; Miller AK; Selgrade SE; Miller SI; Denton M; Conway SP; Johansen HK; Høiby N
Antimicrob Agents Chemother; 2012 Feb; 56(2):1019-30. PubMed ID: 22106224
[TBL] [Abstract][Full Text] [Related]
9. PhoP-PhoQ homologues in Pseudomonas aeruginosa regulate expression of the outer-membrane protein OprH and polymyxin B resistance.
Macfarlane EL; Kwasnicka A; Ochs MM; Hancock RE
Mol Microbiol; 1999 Oct; 34(2):305-16. PubMed ID: 10564474
[TBL] [Abstract][Full Text] [Related]
10. The Efflux Pump MexXY/OprM Contributes to the Tolerance and Acquired Resistance of Pseudomonas aeruginosa to Colistin.
Puja H; Bolard A; Noguès A; Plésiat P; Jeannot K
Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 31964794
[TBL] [Abstract][Full Text] [Related]
11. A two-component regulatory system interconnects resistance to polymyxins, aminoglycosides, fluoroquinolones, and β-lactams in Pseudomonas aeruginosa.
Muller C; Plésiat P; Jeannot K
Antimicrob Agents Chemother; 2011 Mar; 55(3):1211-21. PubMed ID: 21149619
[TBL] [Abstract][Full Text] [Related]
12. Polymyxin Susceptibility in Pseudomonas aeruginosa Linked to the MexXY-OprM Multidrug Efflux System.
Poole K; Lau CH; Gilmour C; Hao Y; Lam JS
Antimicrob Agents Chemother; 2015 Dec; 59(12):7276-89. PubMed ID: 26369970
[TBL] [Abstract][Full Text] [Related]
13. The MerR-like regulator BrlR impairs Pseudomonas aeruginosa biofilm tolerance to colistin by repressing PhoPQ.
Chambers JR; Sauer K
J Bacteriol; 2013 Oct; 195(20):4678-88. PubMed ID: 23935054
[TBL] [Abstract][Full Text] [Related]
14. The two-component system CprRS senses cationic peptides and triggers adaptive resistance in Pseudomonas aeruginosa independently of ParRS.
Fernández L; Jenssen H; Bains M; Wiegand I; Gooderham WJ; Hancock RE
Antimicrob Agents Chemother; 2012 Dec; 56(12):6212-22. PubMed ID: 23006746
[TBL] [Abstract][Full Text] [Related]
15. Impact of two-component regulatory systems PhoP-PhoQ and PmrA-PmrB on colistin pharmacodynamics in Pseudomonas aeruginosa.
Ly NS; Yang J; Bulitta JB; Tsuji BT
Antimicrob Agents Chemother; 2012 Jun; 56(6):3453-6. PubMed ID: 22470116
[TBL] [Abstract][Full Text] [Related]
16. Genomic variations in polymyxin-resistant Pseudomonas aeruginosa clinical isolates and their effects on polymyxin resistance.
Liang Y; Li J; Xu Y; He Y; Jiang B; Wu C; Shan B; Shi H; Song G
Braz J Microbiol; 2023 Jun; 54(2):655-664. PubMed ID: 36930447
[TBL] [Abstract][Full Text] [Related]
17. Resistance and Heteroresistance to Colistin in Pseudomonas aeruginosa Isolates from Wenzhou, China.
Lin J; Xu C; Fang R; Cao J; Zhang X; Zhao Y; Dong G; Sun Y; Zhou T
Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31383654
[TBL] [Abstract][Full Text] [Related]
18. Mutations and expression of PmrAB and PhoPQ related with colistin resistance in Pseudomonas aeruginosa clinical isolates.
Lee JY; Ko KS
Diagn Microbiol Infect Dis; 2014 Mar; 78(3):271-6. PubMed ID: 24412662
[TBL] [Abstract][Full Text] [Related]
19. Alterations in two-component regulatory systems of phoPQ and pmrAB are associated with polymyxin B resistance in clinical isolates of Pseudomonas aeruginosa.
Barrow K; Kwon DH
Antimicrob Agents Chemother; 2009 Dec; 53(12):5150-4. PubMed ID: 19752280
[TBL] [Abstract][Full Text] [Related]
20. Polyamines induce resistance to cationic peptide, aminoglycoside, and quinolone antibiotics in Pseudomonas aeruginosa PAO1.
Kwon DH; Lu CD
Antimicrob Agents Chemother; 2006 May; 50(5):1615-22. PubMed ID: 16641426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]